"Excellence in Eye Care with a Passion for People. Quality care for Lasik Laser Vision Correction, Laser Cataract Surgery, Implant Surgery, Laser Eyelid Lifts (Laser Blepharoplasty), Keratoconus, Cross linking, Laser Intacs, Glaucoma, Diabetes Eye Evaluations, Pterygium, and Comprehensive Ophthalmology. Gerald B Walman, MD, is a Board Certified Ophthalmologist and is actively involved in getting patients to see as close to 20/20 vision as possible. Dr. Walman has provided surgical eye care to his patients in the Phoenix area, and patients seek him and his team from Scottsdale, Sun City, Tempe, Phoenix, Peoria, Arrowhead, Avondale, Goodyear,and most other regions in the area."

During the past decade, Walman Eye Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Walman Eye Center" #1 sponsor was "Shire" with 2 trials, followed by "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Salvat" with 1 trials sponsored and "Santen Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Walman Eye Center" are "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Cataract" (1 trials), "Non-infectious Anterior Uveitis" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "Walman Eye Center" in a lesser frequency.

Most popular intervention types in "Walman Eye Center" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "Vehicle" (2 trials) and "ADX-102 Ophthalmic Solution (0.5%)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Walman Eye Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Walman Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Walman Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Walman Eye Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".